ABT logo
ABT@NYSE
Abbott Laboratories
$ 99.60+1.11 (+1.13%)
买入 ABT
开盘价开盘价
—
最低价今日最低价
—
52周最高价52周最高价
—
最高价今日最高价
—
52周最低价52周最低价
—
市值公司总市值
170.43B
今日成交量今日成交量
11.94M
平均成交量平均成交量
10.74M
市盈率市盈率
31.67

公司简介

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

IPO 日期
1980-03-17
总部
Abbott Park, US
首席执行官
Robert Ford
板块
Healthcare
行业
Medical - Devices

财务报表

财报

相关公司

BDX logo
BDXBecton, Dickinson and Company
183.75
BSX logo
BSXBoston Scientific Corporation
42.73
DHR logo
DHRDanaher Corporation
219.87
EW logo
EWEdwards Lifesciences Corporation
85.21

Unlok · 交易的未来

借助 AI 驱动洞察,无缝连接全球市场,让交易更智能、更自信。

设备展示图